Evaluate the problem solved, characterization, reproducibility, and evidence before using the format as the centerpiece of the product story.
The source context
The FTC’s health-products guidance evaluates the evidence behind objective claims. A technology name is not a substitute for evidence relevant to the formulation, use conditions, and message. Source ↗
PCG perspective · The following is our proposed development framework, not a finding of the cited source.
Ask what the technology is intended to solve
Begin with the specific development problem. Is the team exploring ingredient handling, product experience, stability, or a performance question? The answer shapes what needs to be characterized and tested. If the only rationale is that the term sounds advanced, the brief needs more work. A technology should earn its place by serving a defined requirement.
Request a characterization plan
Ask the development partner how it will describe and verify the proposed system, what methods will be used, and what acceptance criteria are meaningful for the product. Request a clear distinction between supplier data and finished-product data. The goal is to make the technical work understandable enough that a commercial decision can be made without relying on a single impressive chart.
Evaluate manufacturing and storage together
Discuss what may change between a small development batch and routine production. Include processing, packaging, transport, and intended storage conditions in the review. Ask who will investigate deviations and how changes will be documented. A format that is difficult to characterize or reproduce deserves additional scrutiny before a launch date becomes fixed.
Make the communication conditional on results
Write the intended communication as a question to be answered, not a benefit already won. If the work supports a narrower statement than originally hoped, the product team should be ready to adjust the positioning. This is a stronger route to differentiation than protecting a headline whose assumptions no longer match the product. Novelty has value when it is understandable, reproducible, and relevant to the consumer.
Source & scope
FTC Health Products Compliance Guidance ↗US guidance; checked September 21, 2026. Sources checked September 21, 2026. Product-specific scientific and regulatory conclusions require appropriate specialist review.
How we prepare and update insightsTurn the question into a development brief.
Explore formulation, sourcing, research, or portfolio decisions with Product Concept Group.
Discuss this opportunity ↗